| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CPNS.54 |
| P698 | PubMed publication ID | 30265442 |
| P2093 | author name string | Kalpna Gupta | |
| Varun Sagi | |||
| Barbara A Benson | |||
| Sonal S Joshi | |||
| Waogwende L Song-Naba | |||
| P2860 | cites work | Blood sample collection in small laboratory animals | Q24616699 |
| From Individualized Treatment of Sickle Cell Pain to Precision Medicine: A 40-Year Journey | Q26747771 | ||
| Animal models of β-hemoglobinopathies: utility and limitations | Q28067142 | ||
| Morphine for the treatment of pain in sickle cell disease | Q28087296 | ||
| Quantitative assessment of tactile allodynia in the rat paw | Q29617366 | ||
| Sickle Cell Disease | Q30234741 | ||
| Cardiovascular complications and risk of death in sickle-cell disease | Q30249258 | ||
| Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members | Q30459060 | ||
| High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia | Q30885331 | ||
| Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module | Q33791528 | ||
| Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. | Q34033859 | ||
| An improved procedure for protein staining in polyacrylamide gels with a new type of Coomassie Brilliant Blue | Q34202241 | ||
| Sickle cell pain: a critical reappraisal | Q34296026 | ||
| Sickle cell vaso-occlusion: multistep and multicellular paradigm | Q34530995 | ||
| The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay | Q34734865 | ||
| Daily assessment of pain in adults with sickle cell disease | Q34736115 | ||
| The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations | Q34752970 | ||
| Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study | Q35041547 | ||
| Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease | Q35196490 | ||
| Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease | Q35230235 | ||
| Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain? | Q35843541 | ||
| Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease | Q35848672 | ||
| The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy | Q35848692 | ||
| Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia | Q36015427 | ||
| Comparative Analysis of Pain Behaviours in Humanized Mouse Models of Sickle Cell Anemia. | Q36096001 | ||
| Sickle cell trait diagnosis: clinical and social implications | Q36419951 | ||
| Patients with sickle cell disease have increased sensitivity to cold and heat | Q36554754 | ||
| Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease | Q36809000 | ||
| Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease | Q36868088 | ||
| Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls | Q37064951 | ||
| Sickle cell disease in mice is associated with sensitization of sensory nerve fibers | Q37070937 | ||
| Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease | Q37179797 | ||
| Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation | Q37216210 | ||
| Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease | Q37489028 | ||
| Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease | Q37736976 | ||
| Frequently asked questions by hospitalists managing pain in adults with sickle cell disease | Q37887687 | ||
| Health-related quality of life in sickle cell disease: past, present, and future | Q38004362 | ||
| The delay time in sickle cell disease after 40 years: A paradigm assessed | Q38341763 | ||
| Common gynecological challenges in adolescents with sickle cell disease | Q38650270 | ||
| Sickle cell disease in the older adult | Q39028346 | ||
| Sensory and Thermal Quantitative Testing in Children With Sickle Cell Disease | Q39161218 | ||
| How we manage iron overload in sickle cell patients | Q39179372 | ||
| A new staining technique for proteins in polyacrylamide gels using coomassie brilliant blue G250. | Q39456868 | ||
| Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice | Q40431909 | ||
| Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice | Q40620939 | ||
| Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use. | Q41635275 | ||
| Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness | Q41996084 | ||
| The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association | Q42109748 | ||
| Correction of sickle cell disease by homologous recombination in embryonic stem cells | Q42193735 | ||
| Pulmonary hypertension and NO in sickle cell | Q42558017 | ||
| Mast cell activation contributes to sickle cell pathobiology and pain in mice | Q42612548 | ||
| Daily Opioid Use Fluctuates as a Function of Pain, Catastrophizing, and Affect in Patients with Sickle Cell Disease: an Electronic Daily Diary Analysis | Q44349172 | ||
| Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin | Q44836521 | ||
| Targeting novel mechanisms of pain in sickle cell disease | Q46051242 | ||
| A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade. | Q46081377 | ||
| Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease | Q46264390 | ||
| Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study | Q48140774 | ||
| Mouse models of sickle cell disease. | Q50648124 | ||
| Pain in sickle cell disease: the future of acute treatment. | Q51701658 | ||
| Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode. | Q52728984 | ||
| Sickle cell disease. | Q52795486 | ||
| Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. | Q53692390 | ||
| Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine | Q67427060 | ||
| High-performance liquid chromatography of human hemoglobins on a new cation exchanger | Q71071184 | ||
| Knockout-transgenic mouse model of sickle cell disease | Q73823833 | ||
| Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool | Q77639254 | ||
| Transgenic sickle mice have vascular inflammation | Q78835117 | ||
| Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance | Q81682302 | ||
| Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia | Q89125129 | ||
| P433 | issue | 1 | |
| P304 | page(s) | e54 | |
| P577 | publication date | 2018-09-28 | |
| P1433 | published in | Current protocols in neuroscience | Q27721712 |
| P1476 | title | Mouse Models of Pain in Sickle Cell Disease | |
| P478 | volume | 85 |
| Q91594586 | Diet and gender influence survival of transgenic Berkley sickle cell mice |
| Q64078541 | Effect of chronic opioid therapy on pain and survival in a humanized mouse model of sickle cell disease |
| Q64228738 | Mast Cells Induce Blood Brain Barrier Damage in SCD by Causing Endoplasmic Reticulum Stress in the Endothelium |
| Q91842406 | Sensitization of nociceptors by prostaglandin E2-glycerol contributes to hyperalgesia in mice with sickle cell disease |
Search more.